In light of the current solid business development, the management of AlzChem Group AG confirms the forecast made for the calendar year 2018. Pursuant to the forecast, sales growth is forecasted in the mid-single-digit percentage range, which translates into revenues between EUR 364.5 million to EUR 378.7 million and EBITDA of EUR 49 million to EUR 54 million.